On 1 February 2023, IPSF submitted a statement delivered on behalf of IPSF, IAPO, and IFPMA for the WHO EB152 agenda item related to substandard and falsified medical products.
Read moreOn World Anti-counterfeit day, 10 June 2021, the IFPMA hosted a joint event with local Pharmaceutical Industry Associations from across the African continent to tackle the topic of falsified medicines and chart a robust response to eliminate falsified medicines in the region.
Read moreThe COVID-19 pandemic has led to a global surge in reported falsified medical products including personal protective equipment, diagnostic tests, and more recently falsified or substandard medicines, “cures” and vaccines.
Read more